Guardant Health Stock Target Price and Analyst Consensus
| GH Stock | USD 17.59 1.52 9.46% |
The current analyst and expert consensus on Guardant Health is Strong Buy, with 11 strong buy opinions. The current projected Guardant Health target price consensus is 53.00 with 18 analyst opinions. The most common way Guardant Health analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Guardant Health executives and customers to further validate their buy or sell advice. Guardant Health buy-or-sell recommendation module provides average expert sentiment on the projected Guardant Health target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Guardant Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Lowest Forecast 48.23 | Highest Forecast 58.83 | Target Price 53 |
Guardant |
It's important to approach Guardant Health's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Guardant Health price targets
Guardant Health's stock target price is an estimate of its future price, usually made by analysts. Using Guardant Health's target price to determine if it is a suitable investment can be done through the following steps:- Look at Guardant Health's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Guardant Health's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Guardant Health Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Guardant Health is a key component of Guardant Health valuation and have some predictive power on the future returns of a Guardant Health.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardant Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cash Cows Invested a lot of shares | |
 | Manufacturing Invested over 40 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | ESG Investing Invested few shares | |
 | Dividend Beast Invested over 70 shares | |
 | Momentum Invested over 200 shares | |
 | Investor Favorites Invested over 200 shares | |
 | Driverless Cars Invested over 70 shares | |
Check out Macroaxis Advice on Guardant Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
The data published in Guardant Health's official financial statements usually reflect Guardant Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Guardant Health. For example, before you start analyzing numbers published by Guardant accountants, it's critical to develop an understanding of what Guardant Health's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Guardant Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Guardant Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Guardant Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Guardant Health. Please utilize our Beneish M Score to check the likelihood of Guardant Health's management manipulating its earnings.